Chromadex Corp
NASDAQ:CDXC

Watchlist Manager
Chromadex Corp Logo
Chromadex Corp
NASDAQ:CDXC
Watchlist
Price: 5.49 USD 1.48% Market Closed
Market Cap: 419.3m USD
Have any thoughts about
Chromadex Corp?
Write Note

Net Margin
Chromadex Corp

1.6%
Current
-20%
Average
0.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
1.6%
=
Net Income
1.5m
/
Revenue
91.7m

Net Margin Across Competitors

Country US
Market Cap 417.4m USD
Net Margin
2%
Country US
Market Cap 1.2T USD
Net Margin
9%
Country US
Market Cap 200.4B USD
Net Margin
14%
Country US
Market Cap 165.1B USD
Net Margin
18%
Country KR
Market Cap 67.4T KRW
Net Margin
24%
Country CH
Market Cap 38.1B CHF
Net Margin
9%
Country US
Market Cap 38.4B USD
Net Margin
20%
Country US
Market Cap 35.8B USD
Net Margin
9%
Country US
Market Cap 26.7B USD
Net Margin
21%
Country US
Market Cap 24B USD
Net Margin
17%
Country CN
Market Cap 163.2B CNY
Net Margin
21%
No Stocks Found

Chromadex Corp
Glance View

Market Cap
417.4m USD
Industry
Life Sciences Tools & Services

Chromadex Corp. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. The company is headquartered in Los Angeles, California and currently employs 115 full-time employees. The company went IPO on 2007-06-25. NAD+ is a coenzyme and a regulator of cellular metabolism. The company operates through three segments: Consumer products, Ingredients, and Analytical reference standards and services segment. The Consumer products segment provides finished dietary supplement products that contain the ingredients directly to consumers as well as to distributors. The Ingredients segment develops and commercializes ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The Analytical reference standards and services segment supplies phytochemical reference standards and other research and development services. Its ingredients include Tru Niagen and Immulina. The Tru Niagen is a form nicotinamide riboside (NR). NR is a member of the vitamin B3 family. Immulina is a spirulina extract.

CDXC Intrinsic Value
2.28 USD
Overvaluation 58%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
1.6%
=
Net Income
1.5m
/
Revenue
91.7m
What is the Net Margin of Chromadex Corp?

Based on Chromadex Corp's most recent financial statements, the company has Net Margin of 1.6%.